Your browser doesn't support javascript.
loading
Effectiveness of the physical activity intervention program in the PREDIMED-Plus study: a randomized controlled trial.
Schröder, Helmut; Cárdenas-Fuentes, Gabriela; Martínez-González, Miguel Angel; Corella, Dolores; Vioque, Jesús; Romaguera, Dora; Alfredo Martínez, J; Tinahones, Francisco J; Miranda, José López; Estruch, Ramon; Bueno-Cavanillas, Aurora; Arós, Fernando; Marcos, Ascensión; Tur, Josep A; Warnberg, Julia; Serra-Majem, Lluis; Martín, Vicente; Vázquez, Clotilde; Lapetra, José; Pintó, Xavier; Vidal, Josep; Daimiel, Lidia; Gaforio, José Juan; Matía-Martín, Pilar; Ros, Emilio; Castañer, Olga; Lassale, Camille; Ruiz-Canela, Miguel; Asensio, Eva M; Basora, Josep; Torres-Collado, Laura; Garcia-Rios, Antonio; Abete, Itziar; Toledo, Estefania; Buil-Cosiales, Pilar; Bullo, Mònica; Goday, Albert; Fitó, Montserrat; Salas-Salvadó, Jordi.
Afiliação
  • Schröder H; Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar, Medical Research Institute (IMIM), Barcelona, Spain. hschroeder@imim.es.
  • Cárdenas-Fuentes G; CIBER Epidemiologia y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. hschroeder@imim.es.
  • Martínez-González MA; Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar, Medical Research Institute (IMIM), Barcelona, Spain.
  • Corella D; Department of Experimental and Health Sciences, Universidad Pompeu Fabra, Barcelona, Spain.
  • Vioque J; Department of Preventive Medicine and Public Health, University of Navarra-Navarra Institute for Health Research, Pamplona, Spain.
  • Romaguera D; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Alfredo Martínez J; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Tinahones FJ; Department of Preventive Medicine, University of Valencia, Valencia, Spain.
  • Miranda JL; CIBER Epidemiologia y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Estruch R; Nutritional Epidemiology Unit, Miguel Hernández University, ISABIAL-FISABIO, Alicante, Spain.
  • Bueno-Cavanillas A; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Arós F; Instituto de Investigación Sanitaria Illes Balears (IdISPa), Hospital Universitario Son Espases, Mallorca, Spain.
  • Marcos A; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Tur JA; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain.
  • Warnberg J; Madrid Institute for Advanced Studies (IMDEA) Food Institute, Madrid, Spain.
  • Serra-Majem L; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Martín V; Department of Endocrinology and Nutrition, Virgen de la Victoria Hospital, Malaga University, Malaga, Spain.
  • Vázquez C; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Lapetra J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.
  • Pintó X; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Vidal J; Department of Internal Medicine, Hospital Clínic, IDIBAPS August Pi i Sunyer Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
  • Daimiel L; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Gaforio JJ; Departament of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Matía-Martín P; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Ros E; OSI ARABA. University Hospital Araba, Department of Cardiology, University of the Basque Country UPV/EHU Vitoria-Gasteiz, Vitoria-Gasteiz, Spain.
  • Castañer O; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Lassale C; Immunonutrition Research Group, Department Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), Madrid, Spain.
  • Ruiz-Canela M; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Asensio EM; Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands, Palma de Mallorca, Spain.
  • Basora J; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Torres-Collado L; Department of Nursing, School of Health Sciences, University of Málaga, Málaga, Spain.
  • Garcia-Rios A; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Abete I; Research Institute of Biomedical and Health Sciences, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Toledo E; CIBER Epidemiologia y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Buil-Cosiales P; Institute of Biomedicine (IBIOMED), University of León, León, Spain.
  • Bullo M; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Goday A; Department of Endocrinology and Nutrition, University Hospital Fundación Jiménez Díaz, Madrid, Spain.
  • Fitó M; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Salas-Salvadó J; Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain.
Int J Behav Nutr Phys Act ; 15(1): 110, 2018 11 13.
Article em En | MEDLINE | ID: mdl-30424822
ABSTRACT

BACKGROUND:

The development and implementation of effective physical activity (PA) intervention programs is challenging, particularly in older adults. After the first year of the intervention program used in the ongoing PREvención con DIeta MEDiterránea (PREDIMED)-Plus trial, we assessed the initial effectiveness of the PA component.

METHODS:

PREDIMED-Plus is an ongoing randomized clinical trial including 6874 participants randomized to an intensive weight-loss lifestyle intervention based on an energy-restricted Mediterranean diet (MedDiet), physical activity promotion and behavioral support and to a control group using MedDiet recommendations but without calorie restriction or PA advice. Body mass index (BMI) and waist circumference (WC) are measured by standard clinical protocols. Duration and intensity of PA is self-reported using the validated REGICOR Short Physical Activity Questionnaire. The primary endpoint of the PREDIMED-Plus trial is a combined cardiovascular

outcome:

myocardial infarction (acute coronary syndromes with positive troponin test), stroke, or cardiovascular mortality. The present study involved secondary analysis of PA data (n = 6059; mean age 65 ± 4.9 years) with one-year changes in total, light, and moderate-to-vigorous PA within and between intervention groups as the outcome. Generalized estimating equation models were fitted to evaluate time trends of PA, BMI, and WC within groups and differences between intervention and control groups.

RESULTS:

After 12 months, average daily MVPA increased by 27.2 (95%CI 5.7;48.7) METs-min/day and 123.1 (95%CI 109.7-136.6) METs-min/day in the control and intervention groups, respectively. Total-PA, light-PA, and MVPA increased significantly (p < 0.01) in both groups. A significant (p < 0.001) time*intervention group interaction was found for Total-PA and MVPA, meaning the PA trajectory over time differed between the intervention and control groups. Age, sex, education level, and BMI did not moderate the effectiveness of the PA intervention. BMI and WC decreased significantly with increasing MVPA, compared with participants who reported no changes in MVPA.

CONCLUSION:

After one year of follow-up, the PREDIMED-Plus PA intervention has been effective in increasing daily PA in older adults. TRIAL REGISTRATION Retrospectively registered at the International Standard Randomized Controlled Trial ( http//www.isrctn.com/ISRCTN89898870 ), registration date 24 July 2014.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exercício Físico / Redução de Peso Tipo de estudo: Clinical_trials / Evaluation_studies / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Behav Nutr Phys Act Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exercício Físico / Redução de Peso Tipo de estudo: Clinical_trials / Evaluation_studies / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Behav Nutr Phys Act Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha